Biliary Atresia: Lessons Learned from the Voluntary German Registry

Abstract

Introduction: Aim of the study was to carry out a 5-year survey of German patients with biliary atresia (BA) and to launch a discussion regarding the feasibility of voluntary registries in unregulated healthcare systems.

Methods: A retrospective analysis of German BA patients born between 2001 and 2005, based on data collected from the voluntary European Biliary Atresia Registry (EBAR), was carried out and supplemented by data from all BA patients who underwent liver transplantation at the only 4 pediatric transplantation centers (pLTx) in Germany which are so far not registered at EBAR. Survival rates were calculated using Kaplan-Meier analysis and compared by Cox regression to determine the predictive value of age at surgery and the influence of the center size (fewer or more than 5 patients/study period) on overall survival and survival with native liver.

Results: A critical review of the 148 German EBAR charts revealed that 11 patients (7.4%) had no biliary atresia. The remaining 137 patients from EBAR together with 46 BA patients who underwent LTx without prior registration at EBAR were evaluated with a median follow-up of 39 months (range: 25–85 months). 29 hospitals performed a total of 159 Kasai procedures, but only 7 centers treated 5 or more patients (116 patients, range: 5–68), and 22 hospitals performed less than 5 KP (43 patients, range: 1–4). Primary LTx was performed in 21 patients (11.5%) and 3 patients died without surgical intervention. 16 patients were lost to follow-up (8.7%). Overall survival after 2 years was 83.3% (139 patients), including 105 patients (63%) who had undergone LTx and 34 patients (20.3%) with native liver. 28 patients died (16.7%), 8 after LTx (5.8%). The experience of the center was the only factor with a significant predictive value for jaundice-free survival with native liver (p=0.001).

Conclusion: 25% of all German BA patients were not registered at EBAR, and 29 clinics were involved in the surgical management of BA patients. Therefore a new approach consisting of an internet-based decentralized registry for rare neonatal liver diseases is outlined which could improve the future management of patients with BA. The centralization of such patients at experienced centers with higher caseloads is necessary in Germany and would improve the outcome of patients with biliary atresia.

Key words

biliary atresia - centralization - registry - rare diseases

References

• 1 Davenport M, De Ville de Goyet J, Stringer MD. et al . Seamless management of biliary atresia in England and Wales (1999–2002).  Lancet. 2004;  363 1354-1357
• 2 Petersen C. Pathogenesis and treatment opportunities for biliary atresia.  Clin Liver Dis. 2006;  10 73-88
• 3 Stringer M. Biliary atresia: service delivery and outcomes.  Sem Ped Surg. 2008;  17 116-122
• 4 Baerg J, Zuppan C, Klooster M. Biliary atresia – a fifteen year review of clinical and pathologic factors associated with liver transplantation.  J Pediatr Surg. 2004;  39 800-803
• 5 Kasai M, Suzuki S. A new operation for “non correctable” biliary atresia: portoenterostomy.  Shijitsu. 1959;  13 457-481
• 6 Davenport M, Puricelli V, Farrant P. et al . The outcome of the older (> or =100 days) infant with biliary atresia.  J Pediatr Surg. 2004;  39 575-581
• 7 Leonhardt J, Kuebler JF, Turowski C. et al . Predictive parameters in children with biliary atresia.  Chirurg. 2009;  80 628-633
• 8 Chardot C, Carton M, Spire-Bendelac N. Epidemiology of biliary atresia in France: a national study 1986–1996.  J Hepatol. 1999;  31 1006-1013
• 9 Mc Kiernan PJ, Baker AJ, Loyd C. British paediatric surveillance unit study of biliary atresia: outcome at 13 years.  J Pediatr Gastroenterol Nutr. 2009;  48 78-81
• 10 Nio M, Ohi R, Miyano T. et al . Japanese Biliary Atresia Registry. Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry.  J Pediatr Surg. 2003;  38 997-1000
• 11 Serinet M, Wildhaber B, Broué P. Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening.  Pediatrics. 2009;  123 1280-1286
• 12 Shneider BL, Brown MB, Haber B. A multicenter study of the outcome of biliary atresia in the United States 1997 to 2000.  J Pediatr. 2006;  148 467-474
• 13 Wildhaber BE, Majno P, Mayr J. Biliary atresia: Swiss national study, 1994–2004.  J Pediatr Gastroenterol Nutr. 2008;  46 299-307
• 14 Schreiber R, Barker C, Roberts E. Biliary atresia: the Canadian experience.  J Pediatr. 2007;  151 659-665
• 15 Petersen C, Harder D, Abola Z. European biliary atresia registries: Summary of a symposium.  Eur J Pediatr Surg. 2008;  18 111-116
• 16 Davenport M, Tizzard SA, Underhill J. The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study.  J Pediatr. 2006;  49 393-400
• 17 Petersen C, Harder D, Melter M. Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia.  Am J Gastroenterol. 2008;  103 712-719
• 18 Utterson EC, Shepherd RW, Sokol RJ. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation.  J Pediatr. 2004;  147 180-185

Correspondence